Citation Impact
Citing Papers
Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice
2023 StandoutNobel
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
TGF-β – an excellent servant but a bad master
2012
Overexpression ofp28/gankyrinin human hepatocellular carcinoma and its clinical significance
2002
New staging system and a registry for perihilar cholangiocarcinoma
2011
Confirmation of the prevention of vertical transmission of Neospora caninum in cattle by the use of embryo transfer
2002
What prognostic factors are important for resected intrahepatic cholangiocarcinoma?
2007
Biomarkers of response to PD-1/PD-L1 inhibition
2017
The Combined Use of Melatonin and an Indoleamine 2,3-Dioxygenase-1 Inhibitor Enhances Vaccine-Induced Protective Cellular Immunity to HPV16-Associated Tumors
2018
New Insights into IDO Biology in Bacterial and Viral Infections
2014
Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: Operative results and long-term outcome
2007
Lipid nanoparticles for mRNA delivery
2021 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Quercetin Induces Apoptosis via Caspase Activation, Regulation of Bcl-2, and Inhibition of PI-3-Kinase/Akt and ERK Pathways in a Human Hepatoma Cell Line (HepG2)
2006 Standout
Molecular Characterization of aMelon necrotic spot virus StrainThat Overcomes the Resistance in Melon and Nonhost Plants
2004
Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases
2016
Macrophages in immunoregulation and therapeutics
2023 Standout
A new staging system for mass-forming intrahepatic cholangiocarcinoma
2001
Serum Cytokeratin 19 Fragment (CYFRA21-1) as a Prognostic Factor in Intrahepatic Cholangiocarcinoma
2007
Lipid nanoparticles (LNP) induce activation and maturation of antigen presenting cells in young and aged individuals
2023 StandoutNobel
Delivery technologies for cancer immunotherapy
2019 Standout
Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement
2009
Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma
2000
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Surgical management of intrahepatic cholangiocarcinoma: A 31-year experience
1998
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Evaluation of Risk Factors and Clinicopathologic Features for Intrahepatic Cholangiocarcinoma in Southern China: A Possible Role of Hepatitis B Virus
2011
Anti-tumor Activity of Toll-Like Receptor 7 Agonists
2017
Metabolic orchestration of the wound healing response
2021
Cancer/testis antigens, gametogenesis and cancer
2005 Standout
Cholangiocarcinoma
2007 Standout
Immune checkpoint inhibitors: recent progress and potential biomarkers
2018 Standout
Identification of Interferon-Stimulated Genes with Antiretroviral Activity
2016 StandoutNobel
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
2019 Standout
TLR-mediated metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy
2018
Laparoscopic versus open liver resection for hepatocellular carcinoma in patients with histologically proven cirrhosis: short- and middle-term results
2007
Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression
2021 StandoutNobel
The Clavien-Dindo Classification of Surgical Complications
2009 Standout
Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma
2004
Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma
2004
Role of indoleamine 2,3-dioxygenase in health and disease
2015
Review of Neospora caninum and neosporosis in animals
2003 Standout
Genetics of Plant Virus Resistance
2005 Standout
“Pruning of biomolecules and natural products (PBNP)”: an innovative paradigm in drug discovery
2015
Epidemiology and Control of Neosporosis andNeospora caninum
2007 Standout
The Janus-Faced Nature of Ido1 in Infectious Diseases: Challenges and Therapeutic Opportunities
2015
Trial Watch: Toll-like receptor agonists in cancer immunotherapy
2018
Codelivery of mRNA with α-Galactosylceramide Using a New Lipopolyplex Formulation Induces a Strong Antitumor Response upon Intravenous Administration
2019
Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs
2015
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival
2002
Toll-like Receptors from the Perspective of Cancer Treatment
2020
Works of Tatsuya Ando being referenced
Toll-like Receptor agonists and alpha-galactosylceramide synergistically enhance the production of interferon-gamma in murine splenocytes
2013
Left hemihepatectomy with microsurgical reconstruction of the right-sided hepatic vasculature
2001
Clinicopathologic analysis of stage II–III hepatocellular carcinoma showing early massive recurrence after liver resection
2000
Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma
1995
Kynurenine production mediated by indoleamine 2,3-dioxygenase aggravates liver injury in HBV-specific CTL-induced fulminant hepatitis
2014
Inhibition of indoleamine 2,3-dioxygenase activity accelerates skin wound healing
2015
Analysis of SMAD4/DPC4 gene alterations in multiploid colorectal carcinomas
2005
Inhibition of induced nitric oxide synthase enhances the anti-tumor effects on cancer immunotherapy using TLR7 agonist in mice
2015
Inhibition of indoleamine 2,3‐dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice
2015
Comparative study on genomes of two Japanese melon necrotic spot virus isolates.
2000
Induction of hepatitis B virus surface antigen‐specific cytotoxic T lymphocytes can be up‐regulated by the inhibition of indoleamine 2, 3‐dioxygenase activity
2014
Inhibition of indoleamine 2,3‐dioxygenase activity enhances the anti‐tumour effects of a T oll‐like receptor 7 agonist in an established cancer model
2014
Mass Outbreak of Verrucous Dermatitis and Digital Papillomatosis Caused byTreponema-like Spirochetes in Dairy Cattle
2000
Laparoscopic partial hepatectomy.
1998
Blockade of Indoleamine 2,3-Dioxygenase Reduces Mortality from Peritonitis and Sepsis in Mice by Regulating Functions of CD11b+Peritoneal Cells
2014